BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Zentaris GmbH (AEterna GmbH and Zentaris AG Merged) 

Daimlerstraße 40a
Gebäude 108
Frankfurt    60314  Germany
Phone: 069-42-60-23-791 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Shionogi & Co., Ltd. And Nippon Kayaku Co., Ltd. To Release Cetrotide In Japan 9/21/2006 3:44:33 PM
AEterna Laboratories Inc. (AELA) / Zentaris GmbH (AELA) To Present Today Additional Detailed Positive Phase II Data On Cetrorelix In Gynecological Indications At The 18th World Congress Of The International Federation Of Fertility Societies (IFFS)10/19/2005 5:11:29 PM
AEterna Laboratories Inc./Zentaris GmbH (AELA) (AELA) To Present Detailed Positive Phase II Data On Cetrorelix And New Preclinical Data On Perifosine During Investor And Analyst Day In New York City10/19/2005 5:11:22 PM
Spectrum Pharmaceuticals (SPPI) Licenses A Fourth-Generation Phase 2 LHRH Antagonist From Zentaris GmbH (AELA)10/19/2005 5:11:07 PM
AEterna Laboratories Inc. / Zentaris GmbH And Solvay Pharmaceuticals, Inc. Report Headline Positive Data From Six Phase II Trials Of Cetrorelix In Three Indications: Endometriosis, Uterine Myomas And Benign Prostatic Hyperplasia10/19/2005 5:11:05 PM
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris GmbH (AELA) Announces Initiation Of Dose Ranging Study For A Novel Oral Agent That Stimulates Growth Hormone Secretion10/19/2005 5:10:59 PM
AEterna Laboratories Inc. (AELA) Expands Pipeline As Zentaris Subsidiary Establishes New Research Collaborations With University Laboratories In France, Germany And Italy10/19/2005 5:10:25 PM
AEterna Laboratories Inc. (AELA) Through Its Subsidiary Zentaris GmbH (AELA) Signs Partnership With Roche (RHHBY) In Brazil For New Treatment Of Leishmaniasis, A Devastating Tropical Disease10/19/2005 5:09:52 PM
AEterna Laboratories Inc. (AELA) Subsidiary Zentaris AG (AELA) And Solvay Pharmaceuticals, Inc. Sign Extensive Collaboration Agreement10/19/2005 5:09:47 PM